LANDI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 557
EU - Europa 431
AS - Asia 108
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.102
Nazione #
US - Stati Uniti d'America 555
IE - Irlanda 137
GB - Regno Unito 88
CN - Cina 55
IT - Italia 55
SE - Svezia 53
VN - Vietnam 32
UA - Ucraina 28
FR - Francia 16
DE - Germania 13
FI - Finlandia 10
SG - Singapore 9
RU - Federazione Russa 7
BE - Belgio 6
CZ - Repubblica Ceca 6
TR - Turchia 4
NL - Olanda 3
CA - Canada 2
CH - Svizzera 2
CO - Colombia 2
EG - Egitto 2
HK - Hong Kong 2
KZ - Kazakistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AT - Austria 1
BO - Bolivia 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
NO - Norvegia 1
PL - Polonia 1
PT - Portogallo 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.102
Città #
Dublin 137
Fairfield 82
Southend 81
Ashburn 55
Woodbridge 50
Seattle 39
Ann Arbor 38
Houston 35
Chandler 32
Dong Ket 32
Siena 29
Wilmington 28
Cambridge 24
Jacksonville 22
New York 20
Princeton 15
Beijing 14
Dearborn 8
Fremont 8
Helsinki 8
Nanjing 8
San Mateo 8
Shanghai 8
Boardman 7
Brussels 6
Moscow 6
Singapore 6
Redwood City 5
Shenyang 5
Brno 4
Phoenix 4
Changsha 3
Florence 3
Izmir 3
Jiaxing 3
Munich 3
Nanchang 3
Bari 2
Bogotá 2
Cairo 2
Hebei 2
Hong Kong 2
London 2
Ningbo 2
Olomouc 2
San Diego 2
Toronto 2
Almaty 1
Bangkok 1
Gdynia 1
Genova 1
Grosseto 1
Guangzhou 1
Hefei 1
Kaohsiung City 1
Kunming 1
Lanzhou 1
Lisbon 1
Los Angeles 1
Modena 1
Pianella 1
Prescot 1
Reston 1
Sacramento 1
San Fili 1
San Lazzaro di Savena 1
Sucre 1
Taiyuan 1
Tel Aviv 1
Tirana 1
Vienna 1
Zurich 1
Totale 887
Nome #
Profiling of flavonol derivatives for the development of antitrypanosomatidic drugs 174
Enhancement of Benzothiazoles as Pteridine Reductase-1 Inhibitors for the Treatment of Trypanosomatidic Infections 170
Chroman-4-one derivatives targeting pteridine reductase 1 and showing anti-parasitic activity 149
Exploiting the 2-Amino-1,3,4-thiadiazole Scaffold To Inhibit Trypanosoma brucei Pteridine Reductase in Support of Early-Stage Drug Discovery 141
Accelerating Drug Discovery Efforts for Trypanosomatidic Infections Using an Integrated Transnational Academic Drug Discovery Platform 131
Structural Insights into the Development of Cycloguanil Derivatives as Trypanosoma brucei Pteridine-Reductase-1 Inhibitors 106
Development of flavonol and flavanone derivatives as anti-trypanosomatidic drugs 94
High-resolution crystal structure of Trypanosoma brucei pteridine reductase 1 in complex with an innovative tricyclic-based inhibitor 93
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases 40
Multitarget, selective compound design yields potent inhibitors of a Kinetoplastid Pteridine Reductase 1 37
Repurposing the Trypanosomatidic GSK Kinetobox for the Inhibition of Parasitic Pteridine and Dihydrofolate Reductases 20
Totale 1.155
Categoria #
all - tutte 3.647
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.647


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020212 22 8 13 28 17 23 22 17 19 22 5 16
2020/2021250 8 16 5 70 19 19 9 25 11 20 9 39
2021/2022150 3 22 17 19 9 4 6 10 7 9 15 29
2022/2023174 8 9 26 11 17 56 4 15 18 2 6 2
2023/2024206 10 4 18 16 5 54 65 3 2 7 0 22
2024/202513 13 0 0 0 0 0 0 0 0 0 0 0
Totale 1.155